Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-01-25FDA Approved: ALOGLIPTIN — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approves the original application for alogliptin for adults with type 2 diabetes mellitus to improve glycemic control.
-
FDA approval · 2013-01-25FDA Approved: ALOGLIPTIN AND PIOGLITAZONE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a fixed-dose combination product containing alogliptin and pioglitazone from Padagis Israel Pharmaceuticals Ltd for type 2 diab…
-
FDA approval · 2013-01-25FDA Approved: KAZANO — Original Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved KAZANO, a fixed-dose combination of alogliptin and metformin hydrochloride, as a new product for managing type 2 diabetes m…
-
FDA approval · 2012-12-13FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
The FDA approved a supplemental application for Novo Nordisk’s insulin aspart protamine and insulin aspart mix 70/30.
-
FDA approval · 2012-12-13FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals' supplemental application for liraglutide, approving changes to the product's labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-12-07FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUVIA (sitagliptin) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2012-12-03FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for liraglutide submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2012-11-07FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2012-11-05FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
FDA approval · 2012-11-05FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approves NovoLOG's supplemental application for insulin aspart submitted by Novo Nordisk, updating the approved product.
-
FDA approval · 2012-10-26FDA Approved: PIOGLITAZONE HYDROCHLORIDE — Original Application (Chartwell RX, LLC)
FDA approved an original ANDA for pioglitazone hydrochloride (generic) for Chartwell RX, LLC.
-
FDA approval · 2012-10-18FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Januvia (sitagliptin) from Merck Sharp & Dohme LLC.
-
FDA approval · 2012-10-18FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) submitted by Merck Sharp & Dohme LLC to up…
-
FDA approval · 2012-10-18FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET XR (sitagliptin and metformin hydrochloride) to update the product labeling.
-
FDA approval · 2012-10-05FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Metformin Hydrochloride (Ascend Laboratories, LLC) under an ANDA.
-
FDA approval · 2012-09-28FDA Approved: COZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Cozaar (losartan potassium) filed by Organon LLC.
-
FDA approval · 2012-09-28FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Tradjenta (linagliptin) submitted by Boehringer Ingelheim Pharmaceuticals, Inc. This action …
-
FDA approval · 2012-09-27FDA Approved: GLYBURIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for glyburide from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The action represen…
-
FDA approval · 2012-09-25FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for JENTADUETO (linagliptin and metformin HCl) from Boehringer Ingelheim Pharmaceuticals, Inc., appr…
-
FDA approval · 2012-09-19FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a Supplemental Application for Metformin Hydrochloride by Amneal Pharmaceuticals LLC. This constitutes a new generic drug appro…
-
FDA approval · 2012-09-11FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA has approved a supplemental application for glyburide from Teva Pharmaceuticals USA, Inc., under an ANDA.
-
FDA approval · 2012-08-13FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA has approved a supplemental application for Tradjenta (linagliptin) from Boehringer Ingelheim Pharmaceuticals, Inc., addressing chan…
-
FDA approval · 2012-08-13FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for bromocriptine mesylate (ANDA 078899) submitted by Zydus Pharmaceuticals USA Inc., granting regul…
-
FDA approval · 2012-08-01FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved METFORMIN HYDROCHLORIDE under an original generic application by Mylan Pharmaceuticals Inc. for the treatment of type 2 diabete…
-
FDA approval · 2012-07-20FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original ANDA for metformin hydrochloride, a generic form used to treat type 2 diabetes mellitus (an…